ACM
ALLO icon

Aquatic Capital Management’s Allogene Therapeutics ALLO Stock Holding History

Aquatic Capital Management’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,894
Closed -$71.1K – 1333
2025
Q4 		$71.1K Buy
+51,894
New +$68.5K ﹤0.01% 1222
2023
Q1 		– Sell
-53,100
Closed -$334K – 1225
2022
Q4 		$334K Sell
53,100
-26,900
-34% -$249K 0.02% 608
2022
Q3 		$864K Buy
+80,000
New +$1.09M 0.08% 299
2022
Q2 		– Sell
-3,700
Closed -$34K – 1166
2022
Q1 		$34K Buy
+3,700
New +$38.5K 0.05% 364

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return